Report Detail

Request for Sample of this report

Service & Software Global Candida Infection Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4708339
    • |
  • 17 June, 2026
    • |
  • Global
    • |
  • 136 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Candida Infection Testing market size was valued at US$ 122 million in 2025 and is forecast to a readjusted size of US$ 169 million by 2032 with a CAGR of 4.7% during review period.
To address the issues of high misdiagnosis rates and delayed treatment—stemming from the experience-dependent nature of microscopic observation, the time-consuming process of culture-based methods, and the insufficient specificity of biochemical assays in traditional *Candida* infection detection—advanced *Candida* detection technologies have emerged. Since the breakthrough of PCR technology in the 1980s, this field has evolved through the integration of molecular biology, immunology, and high-throughput sequencing technologies into a systematic diagnostic framework encompassing rapid detection, precise typing, and drug resistance analysis. This technology is now widely applied across clinical departments, public health sectors, specialized population management, and primary healthcare settings.
Driven by escalating demands for precision medicine and technological innovation, the *Candida* infection detection industry is currently transitioning from "empirical treatment" to a model of "precise diagnosis followed by targeted therapy." Companies possessing capabilities in multi-platform technology integration, AI algorithm optimization, and clinical validation are poised to lead this transformation, while those lacking core technological innovation and practical clinical application scenarios face the risk of obsolescence. Looking ahead, as the "Healthy China" strategy deepens and cross-border certification barriers are overcome, the industry is expected to form a multi-billion-dollar industrial ecosystem spanning screening, diagnosis, treatment, and follow-up care—thereby significantly reducing mortality rates associated with invasive fungal diseases and enhancing the quality of life for patients.
This report is a detailed and comprehensive analysis for global Candida Infection Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Candida Infection Testing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Candida Infection Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Candida Infection Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Candida Infection Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Candida Infection Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Candida Infection Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Diagnostics, Abbott Diagnostics, bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Siemens Healthineers, Bruker, Danaher, QuidelOrtho, Luminex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Candida Infection Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Traditional Culture
Molecular Biology Detection
Market segment by Detection Indicators
Antigen Detection
Metabolic Product Detection
Market segment by Sample Types
Blood Sample Detection
Mucosal Surface Samples
Market segment by Application
Medical
Maternal and Child Health
Physical Examination
Aesthetic Medicine
Other
Market segment by players, this report covers
Roche Diagnostics
Abbott Diagnostics
bioMérieux
Becton Dickinson
Thermo Fisher Scientific
Siemens Healthineers
Bruker
Danaher
QuidelOrtho
Luminex
Hologic
Sysmex
Bio‑Rad Laboratories
Cepheid
Qiagen
ARUP Laboratories
Labcorp
Quest Diagnostics
Eurofins Scientific
Synlab
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Candida Infection Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Candida Infection Testing, with revenue, gross margin, and global market share of Candida Infection Testing from 2021 to 2026.
Chapter 3, the Candida Infection Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Candida Infection Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Candida Infection Testing.
Chapter 13, to describe Candida Infection Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Candida Infection Testing by Type
    • 1.3.1 Overview: Global Candida Infection Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Candida Infection Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Traditional Culture
    • 1.3.4 Molecular Biology Detection
  • 1.4 Classification of Candida Infection Testing by Detection Indicators
    • 1.4.1 Overview: Global Candida Infection Testing Market Size by Detection Indicators: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Candida Infection Testing Consumption Value Market Share by Detection Indicators in 2025
    • 1.4.3 Antigen Detection
    • 1.4.4 Metabolic Product Detection
  • 1.5 Classification of Candida Infection Testing by Sample Types
    • 1.5.1 Overview: Global Candida Infection Testing Market Size by Sample Types: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Candida Infection Testing Consumption Value Market Share by Sample Types in 2025
    • 1.5.3 Blood Sample Detection
    • 1.5.4 Mucosal Surface Samples
  • 1.6 Global Candida Infection Testing Market by Application
    • 1.6.1 Overview: Global Candida Infection Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Medical
    • 1.6.3 Maternal and Child Health
    • 1.6.4 Physical Examination
    • 1.6.5 Aesthetic Medicine
    • 1.6.6 Other
  • 1.7 Global Candida Infection Testing Market Size & Forecast
  • 1.8 Global Candida Infection Testing Market Size and Forecast by Region
    • 1.8.1 Global Candida Infection Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Candida Infection Testing Market Size by Region, (2021-2032)
    • 1.8.3 North America Candida Infection Testing Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Candida Infection Testing Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Candida Infection Testing Market Size and Prospect (2021-2032)
    • 1.8.6 South America Candida Infection Testing Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Candida Infection Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche Diagnostics
    • 2.1.1 Roche Diagnostics Details
    • 2.1.2 Roche Diagnostics Major Business
    • 2.1.3 Roche Diagnostics Candida Infection Testing Product and Solutions
    • 2.1.4 Roche Diagnostics Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.2 Abbott Diagnostics
    • 2.2.1 Abbott Diagnostics Details
    • 2.2.2 Abbott Diagnostics Major Business
    • 2.2.3 Abbott Diagnostics Candida Infection Testing Product and Solutions
    • 2.2.4 Abbott Diagnostics Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Diagnostics Recent Developments and Future Plans
  • 2.3 bioMérieux
    • 2.3.1 bioMérieux Details
    • 2.3.2 bioMérieux Major Business
    • 2.3.3 bioMérieux Candida Infection Testing Product and Solutions
    • 2.3.4 bioMérieux Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 bioMérieux Recent Developments and Future Plans
  • 2.4 Becton Dickinson
    • 2.4.1 Becton Dickinson Details
    • 2.4.2 Becton Dickinson Major Business
    • 2.4.3 Becton Dickinson Candida Infection Testing Product and Solutions
    • 2.4.4 Becton Dickinson Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Becton Dickinson Recent Developments and Future Plans
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Candida Infection Testing Product and Solutions
    • 2.5.4 Thermo Fisher Scientific Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.6 Siemens Healthineers
    • 2.6.1 Siemens Healthineers Details
    • 2.6.2 Siemens Healthineers Major Business
    • 2.6.3 Siemens Healthineers Candida Infection Testing Product and Solutions
    • 2.6.4 Siemens Healthineers Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Siemens Healthineers Recent Developments and Future Plans
  • 2.7 Bruker
    • 2.7.1 Bruker Details
    • 2.7.2 Bruker Major Business
    • 2.7.3 Bruker Candida Infection Testing Product and Solutions
    • 2.7.4 Bruker Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bruker Recent Developments and Future Plans
  • 2.8 Danaher
    • 2.8.1 Danaher Details
    • 2.8.2 Danaher Major Business
    • 2.8.3 Danaher Candida Infection Testing Product and Solutions
    • 2.8.4 Danaher Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Danaher Recent Developments and Future Plans
  • 2.9 QuidelOrtho
    • 2.9.1 QuidelOrtho Details
    • 2.9.2 QuidelOrtho Major Business
    • 2.9.3 QuidelOrtho Candida Infection Testing Product and Solutions
    • 2.9.4 QuidelOrtho Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 QuidelOrtho Recent Developments and Future Plans
  • 2.10 Luminex
    • 2.10.1 Luminex Details
    • 2.10.2 Luminex Major Business
    • 2.10.3 Luminex Candida Infection Testing Product and Solutions
    • 2.10.4 Luminex Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Luminex Recent Developments and Future Plans
  • 2.11 Hologic
    • 2.11.1 Hologic Details
    • 2.11.2 Hologic Major Business
    • 2.11.3 Hologic Candida Infection Testing Product and Solutions
    • 2.11.4 Hologic Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hologic Recent Developments and Future Plans
  • 2.12 Sysmex
    • 2.12.1 Sysmex Details
    • 2.12.2 Sysmex Major Business
    • 2.12.3 Sysmex Candida Infection Testing Product and Solutions
    • 2.12.4 Sysmex Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sysmex Recent Developments and Future Plans
  • 2.13 Bio‑Rad Laboratories
    • 2.13.1 Bio‑Rad Laboratories Details
    • 2.13.2 Bio‑Rad Laboratories Major Business
    • 2.13.3 Bio‑Rad Laboratories Candida Infection Testing Product and Solutions
    • 2.13.4 Bio‑Rad Laboratories Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Bio‑Rad Laboratories Recent Developments and Future Plans
  • 2.14 Cepheid
    • 2.14.1 Cepheid Details
    • 2.14.2 Cepheid Major Business
    • 2.14.3 Cepheid Candida Infection Testing Product and Solutions
    • 2.14.4 Cepheid Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Cepheid Recent Developments and Future Plans
  • 2.15 Qiagen
    • 2.15.1 Qiagen Details
    • 2.15.2 Qiagen Major Business
    • 2.15.3 Qiagen Candida Infection Testing Product and Solutions
    • 2.15.4 Qiagen Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Qiagen Recent Developments and Future Plans
  • 2.16 ARUP Laboratories
    • 2.16.1 ARUP Laboratories Details
    • 2.16.2 ARUP Laboratories Major Business
    • 2.16.3 ARUP Laboratories Candida Infection Testing Product and Solutions
    • 2.16.4 ARUP Laboratories Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 ARUP Laboratories Recent Developments and Future Plans
  • 2.17 Labcorp
    • 2.17.1 Labcorp Details
    • 2.17.2 Labcorp Major Business
    • 2.17.3 Labcorp Candida Infection Testing Product and Solutions
    • 2.17.4 Labcorp Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Labcorp Recent Developments and Future Plans
  • 2.18 Quest Diagnostics
    • 2.18.1 Quest Diagnostics Details
    • 2.18.2 Quest Diagnostics Major Business
    • 2.18.3 Quest Diagnostics Candida Infection Testing Product and Solutions
    • 2.18.4 Quest Diagnostics Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.19 Eurofins Scientific
    • 2.19.1 Eurofins Scientific Details
    • 2.19.2 Eurofins Scientific Major Business
    • 2.19.3 Eurofins Scientific Candida Infection Testing Product and Solutions
    • 2.19.4 Eurofins Scientific Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.20 Synlab
    • 2.20.1 Synlab Details
    • 2.20.2 Synlab Major Business
    • 2.20.3 Synlab Candida Infection Testing Product and Solutions
    • 2.20.4 Synlab Candida Infection Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Synlab Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Candida Infection Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Candida Infection Testing by Company Revenue
    • 3.2.2 Top 3 Candida Infection Testing Players Market Share in 2025
    • 3.2.3 Top 6 Candida Infection Testing Players Market Share in 2025
  • 3.3 Candida Infection Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Candida Infection Testing Market: Region Footprint
    • 3.3.2 Candida Infection Testing Market: Company Product Type Footprint
    • 3.3.3 Candida Infection Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Candida Infection Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Candida Infection Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Candida Infection Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Candida Infection Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Candida Infection Testing Consumption Value by Type (2021-2032)
  • 6.2 North America Candida Infection Testing Market Size by Application (2021-2032)
  • 6.3 North America Candida Infection Testing Market Size by Country
    • 6.3.1 North America Candida Infection Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Candida Infection Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Candida Infection Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Candida Infection Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Candida Infection Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe Candida Infection Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe Candida Infection Testing Market Size by Country
    • 7.3.1 Europe Candida Infection Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Candida Infection Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France Candida Infection Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Candida Infection Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Candida Infection Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Candida Infection Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Candida Infection Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Candida Infection Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Candida Infection Testing Market Size by Region
    • 8.3.1 Asia-Pacific Candida Infection Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China Candida Infection Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Candida Infection Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Candida Infection Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India Candida Infection Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Candida Infection Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Candida Infection Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Candida Infection Testing Consumption Value by Type (2021-2032)
  • 9.2 South America Candida Infection Testing Consumption Value by Application (2021-2032)
  • 9.3 South America Candida Infection Testing Market Size by Country
    • 9.3.1 South America Candida Infection Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Candida Infection Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Candida Infection Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Candida Infection Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Candida Infection Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Candida Infection Testing Market Size by Country
    • 10.3.1 Middle East & Africa Candida Infection Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Candida Infection Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Candida Infection Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Candida Infection Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Candida Infection Testing Market Drivers
  • 11.2 Candida Infection Testing Market Restraints
  • 11.3 Candida Infection Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Candida Infection Testing Industry Chain
  • 12.2 Candida Infection Testing Upstream Analysis
  • 12.3 Candida Infection Testing Midstream Analysis
  • 12.4 Candida Infection Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Candida Infection Testing. Industry analysis & Market Report on Candida Infection Testing is a syndicated market report, published as Global Candida Infection Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Candida Infection Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo